What biomarkers or precision dx to get for prostate screening
For prostate cancer screening and diagnosis, there are several biomarkers and precision diagnostics that can provide helpful information:
-
Prostate-Specific Antigen (PSA) Test - This is a blood test that measures the level of PSA, a protein produced by the prostate gland. While not perfect, elevated PSA levels may indicate prostate cancer. However, other conditions like prostatitis can also raise PSA.
-
Prostate Health Index (PHI) - This is a formula that combines total PSA, free PSA, and [-2]proPSA measurements to better distinguish prostate cancer from benign conditions. It may help identify which men should have a biopsy.
-
4Kscore Test - This blood test measures 4 prostate-specific kallikrein proteins to estimate the probability of having high-grade prostate cancer if a biopsy were performed.
-
PCA3 Test - This urine test detects the PCA3 gene that is overexpressed in prostate cancer cells. It helps determine if a prostate rebiopsy is needed after a negative initial biopsy.
-
ExoDx Prostate IntelliScore (EPI) - A urine test that analyzes exosomal RNA strands to assess the risk of high-grade prostate cancer prior to an initial biopsy.
-
Genomic Biomarkers - Tests like Prolaris, OncotypeDX, Decipher that analyze tumor genetics/genomics to predict aggression and guide treatment in diagnosed cases.
The NCCN and ASCO guidelines recommend considering these biomarkers and tests selectively based on factors like PSA levels and previous biopsy results when screening for prostate cancer. They can provide additional risk stratification beyond just PSA alone.
Your next question, already answered
Tap to keep going. 2 free answers, then a free account.
Ask Navis about your case
That answer is general. Ask about your specific situation. Answered right here.
For informational purposes only
This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.
Sources & medical oversight
- Grounded in NCCN Guidelines for Patients: Prostate Cancer — the same guidelines oncologists use.
- Built by OpenCancer’s team of physician-scientists and cancer survivors.
- Last updated October 15, 2025. Informational only — not a substitute for your oncology team.
Facing this with someone you love?
Keep the whole picture in one private place: records, a plain-language summary of where things stand, questions, and the people helping. Navis keeps it up to date so no one has to re-explain the story. Free, and only the people you invite can ever see it.
Start a care circle →Source Guidelines
NCCN Guidelines for Patients: Prostate Cancer (2026)Browse all NCCN Guidelines for Patients →Related Services
Services that may help with diagnosis for Prostate Cancer patients
Have your records handy? Add them to a private case for a deeper, personalized read →
More questions about Prostate Cancer
- What biomarker testing is recommended for locally advanced Prostate Cancer
- Given my personal risk factors, what screening tests and frequency are recommended to detect Prostate Cancer early
- Which tests should I get, diagnostic, precision tests etc. that might not normally get ordered from the PCP? I want...
- What are my initial treatment options for Prostate Cancer, and should targeted or immunotherapy based on biomarkers...
- What clinical trials for biomarkers that are specific for advanced prostate cancer that will make pluvicto more...
- If my cancer progresses or is metastatic, what is the sequence of therapies likely to be? How do biomarker results...
- In more detail how the various biomarker test results, such as PSA, 4Kscore, PHI, and molecular profiling tests,...
- What does progression mean for Prostate Cancer and what happens next